NEW YORK ( TheStreet) -- Shares of NPS Pharmaceuticals Inc (Nasdaq: NPSP) were gapping down Monday morning with an open price 11% lower than Friday's closing price. The stock closed at $7.76 Friday and opened today's trading at $6.91. The average volume for NPS has been 909,700 shares per day over the past 30 days. NPS has a market cap of $616 million and is part of the health care sector and drugs industry. Shares are down 2.2% year to date as of the close of trading on Friday. NPS Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the development specialty therapeutics for gastrointestinal and endocrine disorders. TheStreet Ratings rates NPS as a sell. The company's weaknesses can be seen in multiple areas, such as its poor profit margins and weak operating cash flow. You can view the full NPS Ratings Report. Get more investment ideas from our investment research center. Interested in other stocks that are gapping down? Get free SMS text alerts sent to you when the action happens by texting DOWN to 95370 or select from multiple alert options.